1. Home
  2. TAK vs JCI Comparison

TAK vs JCI Comparison

Compare TAK & JCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • JCI
  • Stock Information
  • Founded
  • TAK 1781
  • JCI 1885
  • Country
  • TAK Japan
  • JCI Ireland
  • Employees
  • TAK N/A
  • JCI N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • JCI Industrial Machinery/Components
  • Sector
  • TAK Health Care
  • JCI Industrials
  • Exchange
  • TAK Nasdaq
  • JCI Nasdaq
  • Market Cap
  • TAK 43.9B
  • JCI 47.1B
  • IPO Year
  • TAK N/A
  • JCI N/A
  • Fundamental
  • Price
  • TAK $13.63
  • JCI $84.41
  • Analyst Decision
  • TAK
  • JCI Buy
  • Analyst Count
  • TAK 0
  • JCI 17
  • Target Price
  • TAK N/A
  • JCI $76.60
  • AVG Volume (30 Days)
  • TAK 1.3M
  • JCI 4.0M
  • Earning Date
  • TAK 10-31-2024
  • JCI 11-06-2024
  • Dividend Yield
  • TAK 4.65%
  • JCI 1.75%
  • EPS Growth
  • TAK 49.73
  • JCI N/A
  • EPS
  • TAK 1.27
  • JCI 2.52
  • Revenue
  • TAK $31,732,209,416.00
  • JCI $22,952,000,000.00
  • Revenue This Year
  • TAK $4.41
  • JCI $8.64
  • Revenue Next Year
  • TAK $1.09
  • JCI $4.10
  • P/E Ratio
  • TAK $21.56
  • JCI $40.58
  • Revenue Growth
  • TAK 9.43
  • JCI N/A
  • 52 Week Low
  • TAK $12.58
  • JCI $51.41
  • 52 Week High
  • TAK $15.08
  • JCI $87.16
  • Technical
  • Relative Strength Index (RSI)
  • TAK 39.22
  • JCI 66.69
  • Support Level
  • TAK $13.46
  • JCI $84.56
  • Resistance Level
  • TAK $13.75
  • JCI $87.16
  • Average True Range (ATR)
  • TAK 0.16
  • JCI 1.75
  • MACD
  • TAK -0.01
  • JCI 0.69
  • Stochastic Oscillator
  • TAK 21.15
  • JCI 79.40

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About JCI Johnson Controls International plc

Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration units, and fire and security solutions. Commercial HVAC accounts for over 45% of sales, fire and security represents roughly 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 15% of revenue. In fiscal 2023, Johnson Controls generated nearly $27 billion in revenue.

Share on Social Networks: